Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

84 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

NCT03744676

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Local Institution - 0057 Los Angeles, California, United States
  • Local Institution - 0060 Denver, Colorado, United States
  • Local Institution - 0089 Miami, Florida, United States
  • Local Institution - 0081 Orlando, Florida, United States
View all 23 locations
View Trial Details
Completed

Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)

NCT03483103

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Local Institution - 0043 Gilbert, Arizona, United States
  • Scripps Clinic La Jolla, California, United States
  • UNC School of Medicine Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

NCT04121507

Conditions
Aggressive Non-hodgkin Lymphoma (aNHL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • HELIOS Klinik Berlin-Buch, Klinik für Hämatologie und Stammzelltransplantation Berlin, Brandenburg, Germany
  • Klinikum Augsburg, Medizinische Klinik II Augsburg, Germany
  • Medizinisches Universitätsklinikum Bochum, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 13 locations
View Trial Details

Related conditions